Roles of non-coding RNA in diabetic cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Molecular Biology

Background:

• Diabetes incidence is rising globally, increasing cardiovascular disease risk.
• Diabetic cardiomyopathy (DCM) is a major complication, leading to heart failure and mortality.
• The precise molecular mechanisms underlying DCM pathogenesis are not fully elucidated.

Purpose of the Study:

• To review the current understanding of non-coding RNAs (ncRNAs) in DCM.
• To summarize the roles of microRNAs, long ncRNAs, and circular RNAs in DCM.
• To identify potential therapeutic targets for DCM prevention and treatment.

Main Methods:

• Literature review of recent studies on ncRNAs and DCM.
• Analysis of molecular mechanisms involving ncRNAs in diabetic hearts.
• Synthesis of evidence on microRNAs, long ncRNAs, and circular RNAs in DCM pathophysiology.

Main Results:

• ncRNAs, including microRNAs, long ncRNAs, and circular RNAs, are implicated in DCM.
• These ncRNAs influence key pathological processes such as cardiomyocyte hypertrophy, fibrosis, and apoptosis.
• Dysregulation of specific ncRNAs contributes to cardiac dysfunction in diabetes.

Conclusions:

• ncRNAs are critical regulators in the development and progression of DCM.
• Targeting specific ncRNAs offers promising therapeutic strategies for DCM.
• Further research into ncRNA mechanisms can lead to innovative treatments for diabetic heart disease.